VXRT

Vaxart, Inc.

Healthcare · Biotechnology

$85.41 sample

+0.07 (+0.08%) 1D

Market cap

$496.3B

Price as of

2026-10-03

Latest filing

8-K · 2026-08-17

Alerts

8

Price$85.41 +19.61% 3M daily closessample

85.4171.41

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider sell: Chief Financial Officer
Sep 22INSInsider sell: Chief Financial Officer
Sep 11INSInsider buy: EVP, Operations
Sep 07INSInsider buy: 10% owner
Sep 02INSInsider buy: Chief Executive Officer
Aug 25INSInsider sell: EVP, Operations
Aug 17SEC10-Q filed
Aug 06INSInsider buy: General Counsel

Sign up to see the real VXRT record →

Company facts

SEC EDGAR registration

Name: Vaxart, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +12sample, -100 to +100
Reporting currency: USD

Who is positioning in VXRT

sample

Insiders: 34 insider transactions over 90 days, net selling, $520.9M
Congress: 1 members traded over 90 days
Institutions · 13F: 29 funds hold $12.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$20.5B +14.7% y/y

Q4 2024Q3 2026

Inventory$12.5B +21.1% y/y

Q4 2024Q3 2026

Accounts receivable$9.0B +13.7% y/y

Q4 2024Q3 2026

Total debt$24.0B +12.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $315.6B +2.8% 3M
Sample peer B: $53.5B +2.9% 3M
Sample peer C: $136.4B +12.9% 3M
Sample peer D: $252.1B +5.1% 3M
Sample peer E: $101.5B -5.7% 3M